Hirotsu I, Kihara T, Nakamura S, Hattori Y, Hatta M, Kitakaze Y, Takahama K, Hashimoto Y, Miyata T, Ishihara T
Laboratory of Experimental Pharmacology, Suntory Institute for Biomedical Research, Osaka, Japan.
Arzneimittelforschung. 1988 Oct;38(10):1398-409.
The pharmacological actions of N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent, on the central nervous system were studied in various experimental animals as compared with those of disopyramide, mexiletine and lidocaine, and the following results were obtained. 1. Acute toxicity of SUN 1165 in mice was similar to that of mexiletine, and twice as potent as compared with that of disopyramide and lidocaine. Main acute toxic symptoms of SUN 1165 were muscle relaxation, ataxia, clonic convulsions, tremor and a decrease in spontaneous activity in mice, rats and rabbits. In addition to these symptoms, vomiting in dogs was observed. These toxic symptoms were similar to those of lidocaine. In the case of disopyramide, ataxia, tremor and a decrease in spontaneous activity were observed in mice and rats. On the other hand, mexiletine caused central nervous excitatory symptoms, that is, tremor, Straub tail, clonic convulsions, jumping, running and opisthotonus in mice and rats, and vomiting in dogs. 2. SUN 1165 even at large doses (50-100 mg/kg p.o.) exerted no significant effects on the following changes: hexobarbital-induced induced hypnosis, oxotremorine-induced tremor, apomorphine-induced hypothermia, reserpine-induced ptosis and hypothermia, 5-hydroxytryptophan syndrome and fighting behavior in mice, and conditioned avoidance response in rats. 3. An ineffective dose of SUN 1165 (12.5 mg/kg p.o.) on spontaneous locomotor activity was lower than of disopyramide and lidocaine, however, higher than that of mexiletine. 4. SUN 1165 at large doses showed antagonistic action on toxic extensor seizures induced by maximal electroshock, picrotoxin, or strychnine in mice, but anticonvulsive effects of SUN 1165 were less potent than those of mexiletine and lidocaine. SUN 1165 had no effect on clonic convulsions induced by pentetrazol and pictrotoxin in mice, while both mexiletine and lidocaine prolonged the duration of clonic convulsions. 5. The muscle relaxant effect of SUN 1165 (50%-toxic dose, TD50 = 30 mg/kg p.o.) was more marked than that of lidocaine (TD50 = 92 mg/kg p.o.) on traction test in mice. However, effect of SUN 1165 (TD50 = 62 mg/kg p.o.) on motor incoordination was similar to that of disopyramide, mexiletine and lidocaine on the rotarod test in mice. 6. The analgesic effect of SUN 1165 was as weak as that of disopyramide, mexiletine and lidocaine on chemically and mechanically-induced pain response in mice.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了新型抗心律失常药物N-(2,6-二甲基苯基)-8-吡咯烷乙酰胺盐酸盐半水合物(SUN 1165)对各种实验动物中枢神经系统的药理作用,并与丙吡胺、美西律和利多卡因进行了比较,得到以下结果。1. SUN 1165对小鼠的急性毒性与美西律相似,是丙吡胺和利多卡因的两倍。SUN 1165的主要急性毒性症状为小鼠、大鼠和家兔的肌肉松弛、共济失调、阵挛性惊厥、震颤和自发活动减少。除这些症状外,还观察到犬呕吐。这些毒性症状与利多卡因相似。丙吡胺在小鼠和大鼠中可观察到共济失调、震颤和自发活动减少。另一方面,美西律会引起中枢神经兴奋症状,即小鼠和大鼠的震颤、施特劳布尾、阵挛性惊厥、跳跃、奔跑和角弓反张,以及犬呕吐。2. SUN 1165即使大剂量(口服50 - 100 mg/kg)对以下变化也无显著影响:己巴比妥诱导的催眠、毒扁豆碱诱导的震颤、阿扑吗啡诱导的体温过低、利血平诱导的眼睑下垂和体温过低、5-羟色氨酸综合征以及小鼠的争斗行为,以及大鼠的条件回避反应。3. 对自发运动活性无效的SUN 1165剂量(口服12.5 mg/kg)低于丙吡胺和利多卡因,但高于美西律。4. SUN 1165大剂量对小鼠最大电休克、印防己毒素或士的宁诱导的中毒性伸肌惊厥有拮抗作用,但SUN 1165的抗惊厥作用比美西律和利多卡因弱。SUN 1165对小鼠戊四氮和印防己毒素诱导的阵挛性惊厥无影响,而美西律和利多卡因均延长了阵挛性惊厥的持续时间。5. 在小鼠牵引试验中,SUN 1165(50%毒性剂量,TD50 = 30 mg/kg口服)的肌肉松弛作用比利多卡因(TD50 = 92 mg/kg口服)更显著。然而,SUN 1165(TD50 = 62 mg/kg口服)对运动不协调的作用与丙吡胺、美西律和利多卡因在小鼠转棒试验中的作用相似。6. SUN 1165的镇痛作用与丙吡胺、美西律和利多卡因对小鼠化学和机械诱导的疼痛反应的作用一样弱。(摘要截断于250字)